Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis

医学 罗米普洛斯蒂姆 血小板生成素 肝硬化 血小板 内科学 丙型肝炎病毒 慢性肝病 胃肠病学 丙型肝炎 肝病 外科 骨髓 免疫学 病毒 干细胞 造血 生物 遗传学
作者
Mohamed Moussa,Nadia Mowafy
出处
期刊:Journal of Gastroenterology and Hepatology [Wiley]
卷期号:28 (2): 335-341 被引量:52
标识
DOI:10.1111/j.1440-1746.2012.07246.x
摘要

Patients infected with hepatitis C virus (HCV) often develop chronic liver disease, liver cirrhosis and concurrent thrombocytopenia, which manifests as decreased platelet counts and bleeding complications. Romiplostim, a thrombopoietin mimetic peptibody that stimulates the thrombopoietin receptor, has been used as a treatment for primary immune thrombocytopenia. We monitored the efficacy of preoperative romiplostim over 90 days in 35 male patients with chronic hepatitis C, liver cirrhosis and thrombocytopenia secondary to HCV infection.Romiplostim was administered at 2 μg/kg Q1W for a maximum of one month with a target platelet count of 70 × 10(9)/L as a prerequisite for planned surgeries. Bone marrow aspirate was collected at baseline and at the end of the study, along with liver and kidney function assessments. A complete blood count was performed every third day throughout the study period.A rapid response to romiplostim therapy was observed, with 33/35 patients achieving platelet counts ≥ 70 × 10(9)/L and thereby eligible for surgery. An initial mean platelet count of 31 × 10(9)/L increased to a maximum peak range of 73-240 × 10(9)/L, occurring between days 18 and 39. The reticulin bone marrow grade remained negative in all patients. Surgical interventions were associated with no postoperative bleeding or thrombotic complications.Preoperative romiplostim administration may represent a viable alternative to increase platelet counts to a level acceptable for elective surgical interventions in patients with chronic liver disease and severe thrombocytopenia secondary to HCV infection who are unresponsive to standard therapy. Further studies in larger numbers of patients and over a longer period of time are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
大宇发布了新的文献求助10
2秒前
xunxun关注了科研通微信公众号
3秒前
向雫完成签到,获得积分10
3秒前
薛顶饿关注了科研通微信公众号
4秒前
4秒前
wwj完成签到,获得积分10
5秒前
舒心梦玉发布了新的文献求助10
6秒前
花有花期完成签到,获得积分10
6秒前
李爱国应助向雫采纳,获得10
7秒前
tianshicanyi发布了新的文献求助10
8秒前
FashionBoy应助牛羊不吃草采纳,获得10
8秒前
由天与完成签到,获得积分10
11秒前
小马甲应助学术大白采纳,获得10
12秒前
酷波er应助winter采纳,获得10
12秒前
4399com应助菠萝披萨采纳,获得30
12秒前
欣喜惜筠完成签到,获得积分10
14秒前
脑洞疼应助大宇采纳,获得10
17秒前
17秒前
18秒前
19秒前
饱满飞荷完成签到,获得积分10
22秒前
舒心梦玉完成签到,获得积分10
23秒前
24秒前
健壮聪展完成签到,获得积分10
24秒前
huhuhu发布了新的文献求助10
25秒前
淡定乐天完成签到 ,获得积分10
25秒前
25秒前
konosuba完成签到,获得积分10
26秒前
虎纠小鲁发布了新的文献求助50
28秒前
28秒前
隆龙完成签到,获得积分10
28秒前
gzj发布了新的文献求助10
29秒前
薛顶饿完成签到,获得积分10
29秒前
29秒前
香蕉觅云应助机灵石头采纳,获得10
30秒前
30秒前
科研通AI2S应助排骨炖豆角采纳,获得10
32秒前
WEN发布了新的文献求助50
33秒前
SPRETEND发布了新的文献求助10
33秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3301837
求助须知:如何正确求助?哪些是违规求助? 2936365
关于积分的说明 8477483
捐赠科研通 2610167
什么是DOI,文献DOI怎么找? 1425007
科研通“疑难数据库(出版商)”最低求助积分说明 662239
邀请新用户注册赠送积分活动 646373